bluebird bio (BLUE) Misses Q2 EPS by 39c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to bluebird bio (BLUE) Misses Q2 EPS by 39c

bluebird bio Reports Second Quarter Financial Results and Provides Operational Update

August 9, 2021 7:00 AM EDT

- On track to complete planned business separation in 4Q 2021; each company launching with approximately 24 months of runway following separation

- Severe genetic disease (SGD) business to scale back operations in Europe to focus on the U.S. market -

- ABECMA generates strong performance in first quarter of U.S. launch

- FDA has placed studies of elivaldogene autotemcel (eli-cel, Lenti-D) for cerebral adrenoleukodystrophy (CALD) on clinical hold following safety report; other SGD and oncology programs not impacted

... More